STENAMUPORIS Has shown effectiveness in treating obesity, COPD (chronic obstructive pulmonary disease), congestive heart failure and deterioration of lean muscle mass linked with aging. STENAMUPORIS has also shown positive effects on cardiorespiratory performance.
Storage
Store at room temperature away from heat and direct sunlight.
Dosage
20-50mg/Day
Contraindications
STENAMUPORIS can cause fetal harm when administered to pregnant women. It is contraindicated in women who are or may become pregnant. If the patient becomes pregnant while taking the drug, she should be apprised of the potential hazard to the fetus.
Special Precautions
SR-9009 may cause suppression of clotting factors II, V, VII and X, and an increase in prothrombin time. Hemoglobin and hematocrit should be checked periodically for polycythemia in patients who are receiving high doses.
Adverse Drug Reactions
Disclaimer
"Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice."
